Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis by Jacob P. Thyssen, Thomas Bieber, C. Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto, Elisabeth Riedl, Andreas Wollenberg

Connect to this object online.

Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis by Peter A. Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen, Esther Garcia Gil, Marta Casillas, Sherry Chen, Luna Sun, Evangeline Pierce, Hany Elmaraghy, Zach Dawson, Tiago Torres

Connect to this object online.

Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis by Delphine Staumont‐Sallé, Sébastien Barbarot, Jean David Bouaziz, Chan Chan, Claire Clibborn, Aurélie Du‐Thanh, Claire Feeney, Alexandre Lejeune, Laurent Misery, Audrey Nosbaum, Julien Seneschal, Angèle Soria, Fan Zhang

Connect to this object online.

Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis: An international, cross-sectional study by John C. Su, MD, Nikolay Murashkin, MD, Andreas Wollenberg, MD, Åke Svensson, MD, Pavel Chernyshov, MD, Peter Lio, MD, Dedee Murrell, MD, Audrey Nosbaum, MD, Sebastien Faure, MD, Sophie Mery, MD, Jean-François Stalder, MD

Connect to this object online.

Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilCapsule Summary by Lawrence F. Eichenfield, MD, Ayan Kusari, MA, Allison M. Han, MA, Sébastien Barbarot, MD, PhD, MSc, Mette Deleuran, MD, DMSc, Peter Lio, MD, Danielle Marcoux, MD, Audrey Nosbaum, MD, PhD, Jean-Francois Stalder, MD

Connect to this object online.